![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Rosetta Genomics Licenses Roche PCR Technology
Rosetta Genomics Licenses Roche PCR Technology
January 8, 2008
A subsidiary of Israel’s Rosetta Genomics has received a license to use Roche Molecular Systems’ PCR technology in microRNA-based diagnostic tests.
The platform will allow Rosetta to identify microRNA biomarkers in several sample types and body fluids.
Amir Avniel, Rosetta’s president and CEO, said the company will develop a line of microRNA-based products, three of which should launch this year.
Upcoming Events
-
21Oct